Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 11,357 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $20.34, for a total transaction of $231,001.38. The sale was disclosed in a filing with the Securities & Exchange Commission, […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of Aerovate Therapeutics stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $30.00, for a total value of $300,000.00. The transaction was disclosed in a filing with the SEC, which […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price dropped 3.9% on Wednesday after an insider sold shares in the company. The company traded as low as $28.23 and last traded at $28.44. Approximately 5,463 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 121,717 shares. The […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $30.73 and last traded at $28.72, with a volume of 14079 shares. The stock had previously closed at $29.57. Analyst Upgrades and Downgrades A number of equities research analysts have recently […]